SCHEMBL10912741

SCHEMBL10912741

C/C=C\C1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)C(N)c3ccc(O)c(OC)c3)[C@@H]2SC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.76
▸ PTGS2 P35354 1/20 0.76
▸ DRD3 P35462 1/20 0.76
▸ ALDH1A1 P00352 7/20 0.75
▸ MAPT P10636 7/20 0.75
▸ KMT2A Q03164 6/20 0.75
▸ MEN1 O00255 5/20 0.75
▸ HSD17B10 Q99714 7/20 0.56
▸ SLC15A2 Q16348 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ ESR1 P03372 1/20 0.56
▸ SLC22A6 Q4U2R8 1/20 0.56
▸ SLC22A8 Q8TCC7 1/20 0.56
▸ CYP3A4 P08684 4/20 0.54
▸ HPGD P15428 3/20 0.54
▸ TDP1 Q9NUW8 3/20 0.54
▸ CYP2C19 P33261 2/20 0.54
▸ BLM P54132 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ ADRA1A P35348 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10912735 1.00 DRD2 (0.76) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10817030 0.91 PTGS2 (0.82) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10817022 0.91 PTGS2 (0.82) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10586452 0.90 DRD2 (0.70) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10585024 0.89 DRD2 (0.71) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10585030 0.89 DRD2 (0.71) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10795884 0.89 PTGS2 (0.78) DRD2PTGS2DRD3ALDH1A1MAPT
SCHEMBL10795876 0.89 PTGS2 (0.78) DRD2PTGS2DRD3ALDH1A1MAPT
Cefprozil Anhydrous, (E)- SCHEMBL2901170 0.86 PTGS2 (1.00) DRD2PTGS2DRD3ALDH1A1MAPT
Cefprozil Anhydrous, (E)- SCHEMBL5191958 0.86 PTGS2 (1.00) DRD2PTGS2DRD3ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4520022-A BACTERIAL INFECTION IN MAMMALS BRISTOL-MYERS COMPANY (US) 1985-05-28 — — US claimed
US-4591641-A ORAL ANTIBIOTICS; GRAM NEGATIVE AND GRAM POSITIVE BACTERIA ACTIVITY BRISTOL-MYERS COMPANY (US) 1986-05-27 — — US disclosed
US-4520022-A BACTERIAL INFECTION IN MAMMALS BRISTOL-MYERS COMPANY (US) 1985-05-28 — — US disclosed
Send feedback